DE69927507D1 - Zusammensetzungen und verfahren zur behandlung von abnormaler zellvermehrung - Google Patents
Zusammensetzungen und verfahren zur behandlung von abnormaler zellvermehrungInfo
- Publication number
- DE69927507D1 DE69927507D1 DE69927507T DE69927507T DE69927507D1 DE 69927507 D1 DE69927507 D1 DE 69927507D1 DE 69927507 T DE69927507 T DE 69927507T DE 69927507 T DE69927507 T DE 69927507T DE 69927507 D1 DE69927507 D1 DE 69927507D1
- Authority
- DE
- Germany
- Prior art keywords
- abnormal cell
- vitamin
- compositions
- treatment
- cell reproduction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/06—Preparations for styling the hair, e.g. by temporary shaping or colouring
- A61Q5/065—Preparations for temporary colouring the hair, e.g. direct dyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US116632 | 1998-07-16 | ||
US09/116,632 US20010002396A1 (en) | 1998-07-16 | 1998-07-16 | Compositions and methods of treating skin conditions |
PCT/US1999/015769 WO2000003700A1 (en) | 1998-07-16 | 1999-07-13 | Compositions and methods of treating abnormal cell proliferation |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69927507D1 true DE69927507D1 (de) | 2006-02-09 |
DE69927507T2 DE69927507T2 (de) | 2006-03-23 |
Family
ID=22368338
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69927507T Expired - Fee Related DE69927507T2 (de) | 1998-07-16 | 1999-07-13 | Zusammensetzungen und verfahren zur behandlung von abnormaler zellvermehrung |
Country Status (12)
Country | Link |
---|---|
US (2) | US20010002396A1 (de) |
EP (1) | EP1104294B8 (de) |
JP (1) | JP2002527356A (de) |
AT (1) | ATE305296T1 (de) |
AU (1) | AU4988999A (de) |
CA (1) | CA2337138A1 (de) |
DE (1) | DE69927507T2 (de) |
DK (1) | DK1104294T3 (de) |
ES (1) | ES2249900T3 (de) |
MX (1) | MXPA01000492A (de) |
PT (1) | PT1104294E (de) |
WO (1) | WO2000003700A1 (de) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6538037B2 (en) | 1991-01-08 | 2003-03-25 | Bone Care International, Inc. | Methods for preparation and use of 1α,24(S)-dihydroxyvitamin D2 |
US5763429A (en) * | 1993-09-10 | 1998-06-09 | Bone Care International, Inc. | Method of treating prostatic diseases using active vitamin D analogues |
US6242434B1 (en) * | 1997-08-08 | 2001-06-05 | Bone Care International, Inc. | 24-hydroxyvitamin D, analogs and uses thereof |
US6573256B2 (en) | 1996-12-30 | 2003-06-03 | Bone Care International, Inc. | Method of inhibiting angiogenesis using active vitamin D analogues |
US6566353B2 (en) * | 1996-12-30 | 2003-05-20 | Bone Care International, Inc. | Method of treating malignancy associated hypercalcemia using active vitamin D analogues |
US20020128240A1 (en) * | 1996-12-30 | 2002-09-12 | Bone Care International, Inc. | Treatment of hyperproliferative diseases using active vitamin D analogues |
US6503893B2 (en) | 1996-12-30 | 2003-01-07 | Bone Care International, Inc. | Method of treating hyperproliferative diseases using active vitamin D analogues |
US20030129194A1 (en) * | 1997-02-13 | 2003-07-10 | Bone Care International, Inc. | Targeted therapeutic delivery of vitamin D compounds |
US6087350A (en) * | 1997-08-29 | 2000-07-11 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Use of pretreatment chemicals to enhance efficacy of cytotoxic agents |
ATE515265T1 (de) * | 1998-03-27 | 2011-07-15 | Univ Oregon Health & Science | Vitamin d und dessen analoge zur behandlung vom tumoren und anderen hyperproliferativen erkrankungen |
US8263580B2 (en) * | 1998-09-11 | 2012-09-11 | Stiefel Research Australia Pty Ltd | Vitamin formulation |
US20090098065A1 (en) * | 2000-01-11 | 2009-04-16 | Avikam Harel | Composition and methods for the treatment of skin disorders |
DE10010814A1 (de) * | 2000-03-08 | 2001-09-13 | Basf Ag | Verwendung von 4-Oxoretinol und dessen Derivaten in kosmetischen Zubereitungen |
EP2070911A2 (de) * | 2000-07-18 | 2009-06-17 | Bone Care International, Inc. | Stabilisiertes 1-alpha-Hydroxy-Vitamin D |
US6566399B2 (en) * | 2000-08-03 | 2003-05-20 | Byung-Moo Min | Inhibitor of replicative senescence of human keratinocytes containing retinoic acid as active ingredients |
IL162213A0 (en) * | 2001-12-03 | 2005-11-20 | Novacea Inc | Pharmaceutical compositions containing active vitamin d compounds |
US20030143165A1 (en) * | 2002-01-25 | 2003-07-31 | Allan Evans | NSAID-containing topical formulations that demonstrate chemopreventive activity |
US7273607B2 (en) * | 2002-07-01 | 2007-09-25 | Karl G. Schakel, legal representative | Health enhancement method |
US20050026877A1 (en) * | 2002-12-03 | 2005-02-03 | Novacea, Inc. | Pharmaceutical compositions comprising active vitamin D compounds |
KR20050096953A (ko) * | 2003-02-05 | 2005-10-06 | 갈데르마 리써어치 앤드 디벨로프먼트,에스.엔.씨. | 물의 존재에 민감한 하나 이상의 활성제를 함유하는 반전에멀젼 유형 조성물, 및 미용 및 피부과에서의 그의 용도 |
CN103265477B (zh) * | 2003-02-26 | 2017-01-11 | 苏根公司 | 作为蛋白激酶抑制剂的氨基杂芳基化合物 |
EP1628631A2 (de) * | 2003-06-05 | 2006-03-01 | Achkar, Charles C. | Verfahren zur behandlung von hyperproliferativen zellerkrankungen |
US20050020546A1 (en) * | 2003-06-11 | 2005-01-27 | Novacea, Inc. | Pharmaceutical compositions comprising active vitamin D compounds |
US20060189586A1 (en) * | 2003-06-11 | 2006-08-24 | Cleland Jeffrey L | Pharmaceutical compositions comprising active vitamin D compounds |
FR2862540B1 (fr) * | 2003-11-21 | 2007-03-30 | Galderma Res & Dev | Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile |
US8404667B2 (en) * | 2006-12-29 | 2013-03-26 | Wisconsin Alumni Research Foundation | Compounds, compositions, kits and methods of use to orally and topically treat acne and other skin conditions by 19-Nor vitamin D analog |
FR2871699A1 (fr) * | 2004-06-17 | 2005-12-23 | Galderma Sa | Composition de type emulsion inverse contenant du calcitrol et du 17-propionate de clobetasol, et ses utilisations en cosmetiques et en dermatologie |
US20060003950A1 (en) * | 2004-06-30 | 2006-01-05 | Bone Care International, Inc. | Method of treating prostatic diseases using a combination of vitamin D analogues and other agents |
US7094775B2 (en) * | 2004-06-30 | 2006-08-22 | Bone Care International, Llc | Method of treating breast cancer using a combination of vitamin D analogues and other agents |
US20060177390A1 (en) * | 2005-02-08 | 2006-08-10 | Person John R | Skin cancer prevention method and product |
US20060073107A1 (en) * | 2004-10-04 | 2006-04-06 | Person John R | Use of vitamin D3 (cholecalciferol) in sunscreens |
US20100093674A1 (en) * | 2005-08-04 | 2010-04-15 | Person John R | Skin cancer prevention method and product |
CA2608021A1 (en) * | 2005-05-10 | 2006-11-16 | Dermipsor Ltd. | Compositions and methods for skin care |
BRPI0609630A2 (pt) * | 2005-05-10 | 2010-04-20 | Dermipsor Ltd | composições e métodos para tratamento de doenças epidérmicas hiperproliferativas |
WO2006133828A1 (en) * | 2005-06-17 | 2006-12-21 | Dsm Ip Assets B.V. | Novel use 25-hydroxycholecalciferol in combination with uv-b screening agents |
FR2894465B1 (fr) * | 2005-12-14 | 2010-09-10 | Fabre Pierre Dermo Cosmetique | Utilisation de composes polyinsatures en tant qu'agents blanchissants |
US20080275128A1 (en) | 2007-04-27 | 2008-11-06 | Elliott C Lasser | Compositions and methods for the treatment of inflammatory conditions |
CN105663146B (zh) | 2009-08-14 | 2020-09-11 | 博格有限责任公司 | 用于治疗脱发的维生素d3及其类似物 |
US8747818B1 (en) | 2011-02-07 | 2014-06-10 | Dennis Gross | Self-tanning compositions |
EP3134093B1 (de) * | 2014-04-23 | 2020-09-09 | The Regents of the University of California | Analoga von n-acetylglucosamin und verwendungen davon |
CN106852126A (zh) * | 2014-06-04 | 2017-06-13 | 阿尔邦国际有限公司 | 用于递送皮肤护理用活性成分的透明组合物和方法 |
EP3939593A1 (de) * | 2014-09-10 | 2022-01-19 | Washington University | Zusammensetzungen und verfahren zur behandlung von präkanzerogenen hautläsionen |
CN112805007B (zh) * | 2018-03-07 | 2023-12-15 | 慧源香港创新有限公司 | 用于治疗过度增殖性皮肤障碍的组合物和方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5514672A (en) | 1981-02-17 | 1996-05-07 | Bazzano; Gail S. | Use of retinoids and compositions containing same for hair growth |
WO1984002845A1 (en) * | 1983-01-21 | 1984-08-02 | Advanced Drug Tech | Vitamin-containing skin care ointment |
JPH07100685B2 (ja) * | 1985-08-02 | 1995-11-01 | レオ・ファ−マシュ−ティカル・プロダクツ・リミテッド・エイ/エス(レ−ベンス・ケミスケ・ファブリック・プロデュクチオンスアクチ−セルスカブ) | 新規ビタミンd類似体 |
JPS6360910A (ja) | 1986-09-01 | 1988-03-17 | Shiseido Co Ltd | 皮膚外用剤 |
US5763428A (en) * | 1990-09-21 | 1998-06-09 | Bone Care International, Inc. | Methods of treating skin disorders with novel 1a-hydroxy vitamin D4 compounds and derivatives thereof |
GB9109733D0 (en) * | 1991-05-07 | 1991-06-26 | Unilever Plc | Cosmetic composition |
TW272187B (de) | 1992-05-20 | 1996-03-11 | Hoffmann La Roche | |
US5547947A (en) * | 1993-03-11 | 1996-08-20 | Hoffmann-La Roche Inc. | Methods of treatment |
FR2714595B1 (fr) | 1993-12-30 | 1996-02-02 | Oreal | Emulsion eau dans huile contenant du rétinol, son utilisation et son conditionnement. |
DE69529043T2 (de) | 1994-09-30 | 2003-05-08 | Oreal | Verwendung von einem Agonisten eines mit einem Chloridkanal assozierten Rezeptors zur Behandlung von Hautfalten |
US5786391A (en) | 1995-01-11 | 1998-07-28 | Cornell Research Foundation, Inc. | Regulating gene expression using retinoids with Ch2 OH or related groups at the side chain terminal position |
FR2738745B1 (fr) | 1995-09-15 | 1997-10-24 | Cird Galderma | Nouvelles compositions a base d'un melange synergetique entre au moins un ligand de vdr et un retinoide, et leurs utilisations |
-
1998
- 1998-07-16 US US09/116,632 patent/US20010002396A1/en not_active Abandoned
-
1999
- 1999-07-12 US US09/351,020 patent/US6242435B1/en not_active Expired - Fee Related
- 1999-07-13 CA CA002337138A patent/CA2337138A1/en not_active Abandoned
- 1999-07-13 JP JP2000559835A patent/JP2002527356A/ja not_active Withdrawn
- 1999-07-13 AU AU49889/99A patent/AU4988999A/en not_active Abandoned
- 1999-07-13 DK DK99933947T patent/DK1104294T3/da active
- 1999-07-13 AT AT99933947T patent/ATE305296T1/de not_active IP Right Cessation
- 1999-07-13 MX MXPA01000492A patent/MXPA01000492A/es active IP Right Grant
- 1999-07-13 WO PCT/US1999/015769 patent/WO2000003700A1/en active IP Right Grant
- 1999-07-13 PT PT99933947T patent/PT1104294E/pt unknown
- 1999-07-13 ES ES99933947T patent/ES2249900T3/es not_active Expired - Lifetime
- 1999-07-13 DE DE69927507T patent/DE69927507T2/de not_active Expired - Fee Related
- 1999-07-13 EP EP99933947A patent/EP1104294B8/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US6242435B1 (en) | 2001-06-05 |
US20010002396A1 (en) | 2001-05-31 |
EP1104294A1 (de) | 2001-06-06 |
DE69927507T2 (de) | 2006-03-23 |
ES2249900T3 (es) | 2006-04-01 |
DK1104294T3 (da) | 2006-02-13 |
AU4988999A (en) | 2000-02-07 |
WO2000003700A1 (en) | 2000-01-27 |
EP1104294A4 (de) | 2003-02-05 |
PT1104294E (pt) | 2005-11-30 |
CA2337138A1 (en) | 2000-01-27 |
ATE305296T1 (de) | 2005-10-15 |
MXPA01000492A (es) | 2002-11-29 |
JP2002527356A (ja) | 2002-08-27 |
EP1104294B8 (de) | 2005-11-23 |
EP1104294B1 (de) | 2005-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69927507D1 (de) | Zusammensetzungen und verfahren zur behandlung von abnormaler zellvermehrung | |
DE59407237D1 (de) | Nitrato-aminosäure-disulfide zur therapie von erkrankungen des herz-kreislauf-systems | |
MY129189A (en) | Prostaglandin agonists and their use to treat bone disorders | |
PT76472A (de) | Neue derivate von cycloalka<c>pyrrol-carbonsaeuren verfahren zu ihrer herstellung diese enthaltende mittel und deren verwendung sowie neue cycloalka<c>pyrrol-carbonsaeuren als zwischenstufen und verfahren zu deren herstellung | |
MY141384A (en) | Prevention of loss and restoration of bone mass by certain prostaglandin agonists | |
UA49011C2 (uk) | Похідні циклічної амінокислоти, фармацевтична композиція та спосіб лікування | |
IE840302L (en) | 3-(5-aminopentyl)amino-1-benzazepin-2-one-1-alkanoic acids. | |
IL124954A (en) | Inhibitors of interleukin-1betaconverting enzyme and pharmaceutical compositions containing the same | |
ATE406808T1 (de) | Zusammensetzungen, die kurz-und langkettige fettsäuren enthalten, sowie verfahren zu ihrer anwendung für die kontrolle des körpergewichts | |
UA66745C2 (en) | INTERLEUKIN-1b-CONVERTING ENZYME INHIBITORS, PHARMACEUTICAL COMPOSITION AND A METHOD FOR TREATMENT OF DISEASES | |
EP0911321A3 (de) | Verbindungen zur Behandlung von Osteoporose | |
MY119231A (en) | Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them | |
ATE207349T1 (de) | Thip zur behandlung von schlafstörungen | |
DE69535264D1 (de) | Verfahren zur behandlung von diabetes mittels kgf | |
DE69926400D1 (de) | Zusammensetzung enthaltend insulin-sensibilisierenden wirkstoffe und inhibitoren der fruktose-1,6-bisphosphatase (fbpase) zur behandlung von diabetes | |
AP9801269A0 (en) | Prostaglandin agonists. | |
AU8647101A (en) | Compounds having activity as inhibitors of cytochrome p450rai | |
ATE266030T1 (de) | 1,4,7,10-tetraazabicyclo(8.2.2)tetradecan-2-on, verfahren zu ihrer herstellung und ihrer verwendung für die herstellung von tetraazamacrocyclen | |
DE69516903D1 (de) | Retinoid trienverbindungen und verfahren | |
ATE293595T1 (de) | Thyroidhormon-analoga und verfahren zu ihrer herstellung | |
ATE464378T1 (de) | Verwendung des globulären kopfes von acrp30 zur verstärkung der zunahme von muskelmasse und - differenzierung | |
BR0315247A (pt) | Composição, composição farmacêutica, método de tratamento para uma doença proliferativa celular, e, kit | |
ATE181361T1 (de) | Anti-sickling beta-globin,zusammensetzung und verfahren zur behandlung von sichelzellanämie | |
BR0210493A (pt) | Composição, e, método para remover cerume humano | |
DE69613395D1 (de) | Schwefelenthaltende di-ter-butylphenol-verbindungen brauchbar als entzündungshemmende mittel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |